India's drug pricing authority — the National Pharmaceutical Pricing Authority (NPPA) on Monday (November 13) brought 33 fixed-dose combination drugs under its price regulation.
"In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price," the authority said in a press release.
A notification released by the regulator said drug manufacturers are allowed to charge Goods and Services Tax (GST) only if they have made the payment or it is payable to the government on the retail price mentioned.
NPPA said every retailer and dealer needs to display a price list and a supplementary price list for easy accessibility to any person. The above-mentioned retail price is applicable only to the individual manufacturer and marketer who has applied for the same.
The move is set to make these drugs cheaper. Manufacturers failing to comply with the price cap have to return the overcharged amount along with the interest.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
2024 Lok Sabha Elections | Will Amethi and Rae Bareli see the rise of Priyanka Gandhi as a dominant political figure
May 18, 2024 8:59 AM
Lok Sabha Election 2024: I.N.D.I.A. bloc to hold rally at Mumbai's BKC today
May 17, 2024 5:18 PM
In Ayodhya, voters talk of a promise fulfilled and yearning for development
May 17, 2024 2:10 PM
Fight of heavyweights in Sambalpur where farmers, weavers hold the key
May 17, 2024 12:25 PM